BioCryst: Q1 Earnings Snapshot
By AP News
Published - May 03, 2023, 07:16 AM ET
Last Updated - Jun 21, 2023, 11:31 PM EDT
DURHAM, N.C. (AP) — DURHAM, N.C. (AP) — BioCryst Pharmaceuticals Inc. (BCRX) on Wednesday reported a loss of $53.3 million in its first quarter.
On a per-share basis, the Durham, North Carolina-based company said it had a loss of 28 cents.
The results beat Wall Street expectations. The average estimate of six analysts surveyed by Zacks Investment Research was for a loss of 30 cents per share.
The drugmaker posted revenue of $68.8 million in the period, falling short of Street forecasts. Five analysts surveyed by Zacks expected $72.9 million.
